{"gene":"HESX1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1998,"finding":"HESX1 encodes a homeodomain transcription factor required for forebrain, midline, and pituitary development; the Arg53Cys missense mutation within the homeodomain destroys its ability to bind target DNA in vitro.","method":"Homozygous knock-out mouse, human mutation screening, in vitro DNA binding assay (gel shift)","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1-2 — loss-of-function mouse model with defined phenotype plus in vitro DNA-binding assay; foundational paper with 511 citations","pmids":["9620767"],"is_preprint":false},{"year":1995,"finding":"Hesx1 (Rpx) is expressed as two transcripts encoding an identical 185-amino-acid homeodomain protein; its homeodomain shares 80% identity with Xenopus XANF-1, defining a new homeodomain class; expression is restricted to early embryonic tissues and is absent in adult mice.","method":"Molecular cloning, Northern blot, sequence analysis of transcripts from embryonic stem cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — primary molecular characterization with sequence, transcript analysis, and expression profiling; foundational paper","pmids":["7876132"],"is_preprint":false},{"year":2001,"finding":"HESX1 is a promoter-specific transcriptional repressor with a minimal 36-amino-acid repression domain that suppresses homeodomain-containing activator proteins; disease-associated mutations (R160C, S170L) reduce DNA-binding affinity (wild-type Kd 31 nM; S170L Kd 150 nM; R160C no binding), and R160C acts as a dominant negative by inhibiting wild-type HESX1 DNA binding both in vitro and in cell culture via the repression domain.","method":"Promoter-specific reporter assays, EMSA/gel shift with quantitative Kd measurement, dominant-negative cell culture transfection, deletion mutagenesis of repression domain","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal in vitro and cell-based assays with mutagenesis in a single rigorous study","pmids":["11748154"],"is_preprint":false},{"year":2001,"finding":"Heterozygous HESX1 missense mutation S170L significantly reduces relative DNA-binding activity compared with wild-type HESX1, as demonstrated by gel shift analysis.","method":"Gel shift (EMSA) assay of mutant HESX1-S170L protein","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 — single direct biochemical assay, single lab, consistent with findings in PMID 11748154","pmids":["11136712"],"is_preprint":false},{"year":2003,"finding":"A homozygous I26T mutation in the Engrailed homology 1 (eh1) repressor domain of HESX1 does not affect DNA binding but impairs recruitment of the Groucho/TLE1 corepressor, leading to partial loss of transcriptional repression; this establishes the eh1 domain as the interface for TLE corepressor interaction.","method":"In vitro DNA binding assay, corepressor recruitment assay, reporter gene repression assay in cell culture, patient mutation analysis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal assays (DNA binding, corepressor interaction, transcriptional repression) in a single well-controlled study","pmids":["14561704"],"is_preprint":false},{"year":2003,"finding":"A frameshift deletion mutation (g.1684delG) in HESX1 produces a mutant protein with increased DNA binding, causing enhanced repression of PROP1-dependent gene activity, revealing that gain-of-repressor-function is a novel disease mechanism.","method":"Reporter gene assay measuring PROP1-mediated transcriptional activation in the presence of mutant HESX1","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — cell-based functional assay with clear mechanistic outcome, single lab","pmids":["14557462"],"is_preprint":false},{"year":2010,"finding":"HESX1 interacts with both TLE1 and TLE3 corepressors through its engrailed homology domain to repress PROP1-mediated transcription; TLE1 and TLE3 can also repress PROP1 independently of HESX1 via protein-protein interaction, and ectopic HESX1 expression in transgenic mouse pituitary suppresses terminal differentiation of thyrotrophs and gonadotrophs.","method":"Cell-based reporter assay, co-immunoprecipitation, transgenic mouse overexpression with cell-type differentiation phenotyping","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 1-2 — reciprocal Co-IP, functional reporter assay, and in vivo transgenic validation with multiple orthogonal methods","pmids":["20181723"],"is_preprint":false},{"year":2007,"finding":"DNMT1 (DNA methyltransferase 1) is a HESX1-binding protein identified by yeast two-hybrid screen; interaction requires the entire HESX1 protein and a portion of the DNMT1 N-terminus plus its C-terminal catalytic domain; HESX1-DNMT1 complexes co-immunoprecipitate from cells and co-localise in the nucleus, suggesting DNMT1 recruitment as a mechanism for HESX1-mediated transcriptional repression.","method":"Yeast two-hybrid screen, deletion mapping, co-immunoprecipitation, co-localisation by immunofluorescence","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2-3 — yeast two-hybrid plus Co-IP plus co-localisation; functional consequence inferred but not directly tested, single lab","pmids":["17931718"],"is_preprint":false},{"year":2007,"finding":"Absence of Hesx1 leads to ectopic activation of Wnt/β-catenin signalling within the anterior forebrain expression domain of Hesx1, causing posterior transformation of the anterior forebrain; conditional re-expression of Hesx1 within the anterior forebrain rescues the forebrain defect, establishing that Hesx1 represses Wnt/β-catenin signalling cell-autonomously in the anterior neural plate.","method":"Genetic cell labelling, marker analysis, epistasis via conditional transgenic rescue, in situ hybridisation for Wnt target genes in Hesx1-/- mice","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — epistasis/conditional rescue with genetic cell labelling and molecular markers, strong mechanistic placement within Wnt pathway","pmids":["17360769"],"is_preprint":false},{"year":2000,"finding":"Hesx1 is required cell-autonomously in the anterior neural ectoderm (ANE) for normal forebrain formation; chimera analysis shows that Hesx1-/- visceral endoderm does not cause forebrain defects, but Hesx1-/- cells in the ANE do; absence of Hesx1 in ANE leads to downregulation of Six3 and Rax/Rx by the early somite stage.","method":"Chimeric embryo analysis (ES cell injection into blastocysts), RNA in situ hybridisation for forebrain markers","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — chimeric analysis provides cell-autonomous placement with molecular marker validation","pmids":["10882526"],"is_preprint":false},{"year":2008,"finding":"Hesx1 and Six3 interact genetically in pituitary development: compound heterozygous Six3+/-;Hesx1Cre/+ mice display severe dwarfism and pituitary hypoplasia with expanded and bifurcated Rathke's pouch, phenocopying Hesx1-null defects, revealing a cooperative epistatic relationship between these two homeobox genes in anterior pituitary organogenesis.","method":"Double-heterozygous compound mutant mouse analysis, histology, cell proliferation assays, endocrine phenotyping","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis via compound mutant with defined cellular and endocrine phenotype","pmids":["18775421"],"is_preprint":false},{"year":2008,"finding":"The Xanf1/Hesx1 homeodomain repressor binds the LIM-domain protein Zyxin; the eh1 (Engrailed-type) repressor domain of Xanf1 and LIM2-domain of Zyxin are primarily responsible for the interaction; Zyxin overexpression phenocopies Xanf1 loss-of-function, while repressor-fused Zyxin mimics Xanf1 overexpression, indicating Zyxin acts as a negative modulator of Xanf1 transcriptional repressing activity in the anterior neural plate.","method":"Co-immunoprecipitation, deletion mutant mapping, Xenopus overexpression/loss-of-function embryo assay","journal":"Developmental dynamics","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP with domain mapping plus in vivo Xenopus functional assay, ortholog context consistent with mammalian HESX1","pmids":["18297730"],"is_preprint":false},{"year":2004,"finding":"The transcription factor Otx2 binds conserved sites in the ANF/Hesx1 promoter and is required for its activation in the anterior embryonic region; Pax6 binds a site near the transcriptional start site and inhibits Hesx1 expression (Pax6-/- mice show expanded Hesx1 domain); these factors are key regulators of forebrain-specific Hesx1 gene expression.","method":"Transgenic reporter analysis, in vivo electroporation in chick, Pax6 knockout mouse in situ hybridisation, gel shift/in vivo ChIP-like binding assays","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo promoter analysis with multiple species, loss-of-function genetics, and binding site characterisation; single lab","pmids":["15110720"],"is_preprint":false},{"year":2006,"finding":"Regulatory sequences in the 5' upstream region of Rpx/Hesx1 control early expression in anterior endoderm/neural plate, while 3' regulatory elements are required for late expression in Rathke's pouch; the LIM homeodomain proteins Lim1/Lhx1 and Lhx3 directly bind two LIM protein-binding sites in the 5' upstream region, which are required for Rpx promoter activity in both mice and Xenopus.","method":"Transgenic mouse reporter assay with deletion analysis, EMSA for LIM protein binding to promoter sites, cross-species conservation analysis","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — transgenic deletion analysis plus direct binding assay with two species validation","pmids":["16527264"],"is_preprint":false},{"year":2008,"finding":"Knock-in of the I26T mutation (in the eh1 repressor domain) produces a hypomorphic allele with pituitary defects comparable to Hesx1-null but normal telencephalon, while knock-in of R160C (homeodomain) produces a null allele with forebrain and pituitary defects identical to Hesx1-null mice, demonstrating that eh1 and homeodomain mutations have distinct phenotypic consequences consistent with their distinct molecular defects (corepressor recruitment vs. DNA binding).","method":"Knock-in mouse models, histological and developmental phenotyping, comparison with null allele","journal":"Disease models & mechanisms","confidence":"High","confidence_rationale":"Tier 2 — two independent knock-in alleles with defined molecular defects correlated to in vivo phenotypic outcome","pmids":["19093031"],"is_preprint":false},{"year":1996,"finding":"In Ames dwarf (df) mutant mice, Rpx (Hesx1) expression is not extinguished in the pituitary on embryonic day 13.5, while in Snell dwarf (Pit1dw) mutants Rpx is appropriately downregulated; double-mutant epistasis shows df acts upstream of Pit1 in the pituitary differentiation cascade, placing Hesx1 downregulation as a prerequisite for lineage-specific cell proliferation.","method":"Genetic epistasis with double-mutant analysis, in situ hybridisation for Rpx expression, cell proliferation assays","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with double-homozygous and double-heterozygous analysis plus molecular marker expression","pmids":["8961267"],"is_preprint":false},{"year":2006,"finding":"Two novel homozygous HESX1 mutations (frameshift c.449_450delAC and splice defect c.357+2T>C) produce truncated proteins lacking most or all of the homeodomain that are unable to repress PROP1 activity in a transcriptional reporter assay, confirming that HESX1 repressor function requires an intact homeodomain.","method":"Patient mutation sequencing, transcript analysis, transcriptional repression reporter assay","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — direct functional assay of mutant proteins, mechanistically informative, single lab","pmids":["16940453"],"is_preprint":false}],"current_model":"HESX1 is a paired-like homeodomain transcriptional repressor that acts in the anterior neural ectoderm during early embryogenesis: it binds target DNA via its homeodomain (disrupted by R160C), recruits Groucho/TLE1/TLE3 corepressors via its N-terminal eh1 domain (disrupted by I26T), and DNMT1 via a broader interaction, to suppress homeodomain activators such as PROP1 and repress Wnt/β-catenin signalling in the anterior forebrain; its expression is controlled by Lhx1/Lhx3 (early), Otx2 (activation), and Pax6 (repression), and it interacts genetically with Six3 during pituitary organogenesis, with loss-of-function causing septo-optic dysplasia and hypopituitarism while gain-of-repressor-function mutations also cause congenital pituitary disease."},"narrative":{"teleology":[{"year":1995,"claim":"Establishing that Hesx1 (Rpx) encodes a novel 185-amino-acid homeodomain protein expressed exclusively in early embryonic tissues defined the gene as a developmental transcription factor.","evidence":"Molecular cloning, Northern blot, and sequence analysis from embryonic stem cells","pmids":["7876132"],"confidence":"High","gaps":["No functional assay performed","Target genes and binding sites unknown","Protein-protein interactions uncharacterized"]},{"year":1996,"claim":"Epistasis analysis placed Hesx1 downstream of the Ames dwarf (Prop1) locus and showed that persistent Hesx1 expression blocks pituitary lineage-specific proliferation, establishing Hesx1 downregulation as a prerequisite for pituitary differentiation.","evidence":"Double-mutant epistasis in df and Pit1dw mice with in situ hybridisation and cell proliferation assays","pmids":["8961267"],"confidence":"High","gaps":["Direct transcriptional relationship between PROP1 and HESX1 not tested","Mechanism of Hesx1 downregulation unknown"]},{"year":1998,"claim":"Demonstrating that Hesx1-null mice have forebrain, midline, and pituitary defects and that a patient R53C homeodomain mutation abolishes DNA binding established HESX1 as a disease gene for septo-optic dysplasia and linked its function to homeodomain-mediated DNA binding.","evidence":"Knockout mouse phenotyping, human mutation screening, gel-shift DNA binding assay","pmids":["9620767"],"confidence":"High","gaps":["Transcriptional targets not identified","Repression mechanism unknown","Heterozygous vs homozygous genotype-phenotype correlation incomplete"]},{"year":2000,"claim":"Chimera analysis resolved the tissue requirement, showing Hesx1 is needed cell-autonomously in the anterior neural ectoderm (not visceral endoderm) and its absence leads to loss of Six3 and Rax expression, placing it upstream of these forebrain determinants.","evidence":"ES-cell chimeric embryo analysis with RNA in situ hybridisation","pmids":["10882526"],"confidence":"High","gaps":["Whether Hesx1 directly regulates Six3/Rax transcription or acts indirectly not determined","Downstream signalling pathways not identified"]},{"year":2001,"claim":"Quantitative biochemistry and reporter assays showed HESX1 is a promoter-specific transcriptional repressor that opposes homeodomain activators, with a minimal 36-amino-acid repression domain, and revealed that R160C acts as a dominant negative by sequestering wild-type protein through this domain.","evidence":"EMSA with Kd measurements, deletion mutagenesis, cell-based reporter assays, dominant-negative transfection experiments","pmids":["11748154","11136712"],"confidence":"High","gaps":["Identity of the endogenous corepressor recruited by the repression domain not yet known","Direct genomic targets not identified"]},{"year":2003,"claim":"Identification that the I26T eh1-domain mutation disrupts TLE1 corepressor recruitment without affecting DNA binding, while a gain-of-function frameshift increases DNA binding and repression, established two distinct disease mechanisms — loss of corepressor recruitment and gain of repressor function.","evidence":"Corepressor recruitment assays, DNA binding assays, PROP1-dependent reporter assays, patient mutation analysis","pmids":["14561704","14557462"],"confidence":"High","gaps":["Whether TLE1 is the sole corepressor mediating HESX1 repression in vivo unknown","Structural basis of eh1-TLE interaction not resolved"]},{"year":2004,"claim":"Upstream regulation was defined: Otx2 directly activates Hesx1 through conserved promoter sites, while Pax6 represses it, explaining how Hesx1 expression is restricted to the anterior forebrain domain.","evidence":"Transgenic reporter analysis, in vivo electroporation in chick, Pax6 knockout mouse in situ hybridisation, binding assays","pmids":["15110720"],"confidence":"Medium","gaps":["Whether Otx2 and Pax6 are sufficient to account for all spatial regulation not tested","Chromatin context of regulation not examined"]},{"year":2006,"claim":"Identification of Lhx1/Lhx3 binding sites in the 5' upstream region and separate 3' elements for Rathke's pouch expression resolved the modular regulatory architecture of the Hesx1 locus across developmental stages.","evidence":"Transgenic mouse reporter deletion analysis and EMSA for LIM protein binding, cross-species validation","pmids":["16527264"],"confidence":"Medium","gaps":["In vivo occupancy by Lhx1/Lhx3 not confirmed by ChIP","How 3' regulatory elements integrate with 5' elements during the transition from neural plate to Rathke's pouch unclear"]},{"year":2007,"claim":"Discovery that HESX1 represses Wnt/β-catenin signalling cell-autonomously in the anterior forebrain, with conditional rescue reversing anterior-to-posterior transformation, placed HESX1 squarely within the Wnt antagonism pathway during forebrain patterning.","evidence":"Conditional transgenic rescue in Hesx1-null mice, genetic cell labelling, in situ hybridisation for Wnt targets","pmids":["17360769"],"confidence":"High","gaps":["Direct Wnt pathway target genes repressed by HESX1 not identified","Whether HESX1 represses Wnt ligands, receptors, or intracellular components unclear"]},{"year":2007,"claim":"Identification of DNMT1 as a HESX1-interacting protein suggested an epigenetic repression mechanism involving DNA methylation, adding a second corepressor axis beyond TLE.","evidence":"Yeast two-hybrid screen, deletion mapping, co-immunoprecipitation, immunofluorescence co-localisation","pmids":["17931718"],"confidence":"Medium","gaps":["Functional consequence of HESX1-DNMT1 interaction on target gene methylation not demonstrated","Interaction not validated at endogenous expression levels","Relevance in vivo not tested"]},{"year":2008,"claim":"Knock-in of I26T (eh1) and R160C (homeodomain) mutations in mice dissected domain contributions in vivo: the homeodomain null phenocopies the full knockout (forebrain + pituitary defects), while the eh1 hypomorph selectively disrupts pituitary development, demonstrating that corepressor recruitment is specifically critical for pituitary but dispensable for telencephalon specification.","evidence":"Two independent knock-in mouse models with histological and developmental phenotyping compared to null allele","pmids":["19093031"],"confidence":"High","gaps":["Why the eh1 domain is dispensable for forebrain function not mechanistically explained","Alternative corepressor recruitment in the forebrain not investigated"]},{"year":2008,"claim":"Genetic interaction between Hesx1 and Six3 was demonstrated by compound heterozygotes exhibiting severe pituitary hypoplasia, establishing a cooperative epistatic network between these homeobox genes in anterior pituitary organogenesis.","evidence":"Compound heterozygous Six3+/-;Hesx1Cre/+ mice with histology, proliferation, and endocrine phenotyping","pmids":["18775421"],"confidence":"High","gaps":["Whether HESX1 and Six3 regulate shared target genes or act in parallel unknown","Biochemical interaction between HESX1 and SIX3 proteins not tested"]},{"year":2010,"claim":"Expanded characterisation showed HESX1 represses PROP1-mediated transcription through both TLE1 and TLE3, and that persistent HESX1 expression in transgenic pituitary suppresses terminal differentiation of thyrotrophs and gonadotrophs, confirming the in vivo repressor role against PROP1-driven differentiation.","evidence":"Co-immunoprecipitation, cell-based reporter assay, transgenic mouse pituitary overexpression with cell-type differentiation phenotyping","pmids":["20181723"],"confidence":"High","gaps":["Direct genomic binding sites of the HESX1-TLE complex on PROP1 targets not mapped","Whether TLE1 and TLE3 are redundant or have distinct roles in pituitary cell fate not resolved"]},{"year":null,"claim":"The direct genomic targets of HESX1 remain unidentified genome-wide; the structural basis for its interactions with TLE corepressors and DNMT1 is unresolved; and the mechanism by which it selectively antagonises Wnt/β-catenin signalling in the anterior forebrain has not been molecularly defined.","evidence":"","pmids":[],"confidence":"High","gaps":["No ChIP-seq or equivalent genome-wide binding data","No structural model of HESX1 or its corepressor complexes","Wnt target gene specificity of HESX1-mediated repression unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,2,3,14,16]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2,4,5,6,16]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[7]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,8,9,10,14,15]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8]}],"complexes":[],"partners":["TLE1","TLE3","DNMT1","PROP1","SIX3","ZYX"],"other_free_text":[]},"mechanistic_narrative":"HESX1 is a paired-like homeodomain transcriptional repressor essential for anterior forebrain, midline, and pituitary development during early embryogenesis. It acts cell-autonomously in the anterior neural ectoderm, where it suppresses Wnt/β-catenin signalling and represses homeodomain activators such as PROP1 by recruiting TLE1/TLE3 (Groucho family) corepressors through its N-terminal engrailed homology 1 (eh1) domain and binding target DNA via its homeodomain (Kd ~31 nM), with DNMT1 also recruited as an additional corepressor partner [PMID:11748154, PMID:14561704, PMID:20181723, PMID:17931718, PMID:17360769]. Knock-in studies show that disruption of DNA binding (R160C) phenocopies the null, whereas disruption of TLE recruitment alone (I26T) produces a hypomorphic phenotype with pituitary defects but a normal telencephalon, demonstrating separable domain contributions to forebrain versus pituitary specification [PMID:19093031]. Loss-of-function mutations cause septo-optic dysplasia and combined pituitary hormone deficiency, while a gain-of-repressor-function frameshift mutation reveals that excessive HESX1-mediated repression of PROP1 is also pathogenic [PMID:9620767, PMID:14557462]."},"prefetch_data":{"uniprot":{"accession":"Q9UBX0","full_name":"Homeobox expressed in ES cells 1","aliases":["Homeobox protein ANF","hAnf"],"length_aa":185,"mass_kda":21.4,"function":"Required for the normal development of the forebrain, eyes and other anterior structures such as the olfactory placodes and pituitary gland. Possible transcriptional repressor. Binds to the palindromic PIII sequence, 5'-AGCTTGAGTCTAATTGAATTAACTGTAC-3'. HESX1 and PROP1 bind as heterodimers on this palindromic site, and, in vitro, HESX1 can antagonize PROP1 activation","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9UBX0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HESX1","classification":"Not Classified","n_dependent_lines":16,"n_total_lines":1208,"dependency_fraction":0.013245033112582781},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HESX1","total_profiled":1310},"omim":[{"mim_id":"613986","title":"PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6","url":"https://www.omim.org/entry/613986"},{"mim_id":"613038","title":"PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 1; CPHD1","url":"https://www.omim.org/entry/613038"},{"mim_id":"610125","title":"MICROPHTHALMIA, SYNDROMIC 5; MCOPS5","url":"https://www.omim.org/entry/610125"},{"mim_id":"601802","title":"HESX HOMEOBOX 1; HESX1","url":"https://www.omim.org/entry/601802"},{"mim_id":"600037","title":"ORTHODENTICLE HOMEOBOX 2; OTX2","url":"https://www.omim.org/entry/600037"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/HESX1"},"hgnc":{"alias_symbol":["RPX","ANF"],"prev_symbol":[]},"alphafold":{"accession":"Q9UBX0","domains":[{"cath_id":"1.10.10.60","chopping":"115-185","consensus_level":"medium","plddt":89.5668,"start":115,"end":185}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBX0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBX0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBX0-F1-predicted_aligned_error_v6.png","plddt_mean":71.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HESX1","jax_strain_url":"https://www.jax.org/strain/search?query=HESX1"},"sequence":{"accession":"Q9UBX0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UBX0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UBX0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBX0"}},"corpus_meta":[{"pmid":"9620767","id":"PMC_9620767","title":"Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse.","date":"1998","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9620767","citation_count":511,"is_preprint":false},{"pmid":"12023302","id":"PMC_12023302","title":"Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12023302","citation_count":292,"is_preprint":false},{"pmid":"8565852","id":"PMC_8565852","title":"Rpx: a novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo.","date":"1996","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8565852","citation_count":245,"is_preprint":false},{"pmid":"11136712","id":"PMC_11136712","title":"Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11136712","citation_count":208,"is_preprint":false},{"pmid":"2430471","id":"PMC_2430471","title":"Myocardial recruitment during ANF mRNA increase with volume overload in the rat.","date":"1986","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/2430471","citation_count":204,"is_preprint":false},{"pmid":"3158698","id":"PMC_3158698","title":"Localization of immunoreactive synthetic atrial natriuretic factor (ANF) in the heart of various animal species.","date":"1985","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/3158698","citation_count":191,"is_preprint":false},{"pmid":"8961267","id":"PMC_8961267","title":"The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation.","date":"1996","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/8961267","citation_count":138,"is_preprint":false},{"pmid":"11748154","id":"PMC_11748154","title":"Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11748154","citation_count":104,"is_preprint":false},{"pmid":"17148560","id":"PMC_17148560","title":"HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism.","date":"2006","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/17148560","citation_count":103,"is_preprint":false},{"pmid":"3158789","id":"PMC_3158789","title":"Dopamine receptor antagonists inhibit the natriuretic response to atrial natriuretic factor (ANF).","date":"1985","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/3158789","citation_count":103,"is_preprint":false},{"pmid":"14561704","id":"PMC_14561704","title":"A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction.","date":"2003","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/14561704","citation_count":102,"is_preprint":false},{"pmid":"1849131","id":"PMC_1849131","title":"Anantin--a peptide antagonist of the atrial natriuretic factor (ANF). I. Producing organism, fermentation, isolation and biological activity.","date":"1991","source":"The Journal of antibiotics","url":"https://pubmed.ncbi.nlm.nih.gov/1849131","citation_count":93,"is_preprint":false},{"pmid":"7876132","id":"PMC_7876132","title":"Sequence, genomic organization, and expression of the novel homeobox gene Hesx1.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7876132","citation_count":93,"is_preprint":false},{"pmid":"10882526","id":"PMC_10882526","title":"The homeobox gene Hesx1 is required in the anterior neural ectoderm for normal forebrain formation.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10882526","citation_count":91,"is_preprint":false},{"pmid":"7657806","id":"PMC_7657806","title":"Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium.","date":"1995","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/7657806","citation_count":84,"is_preprint":false},{"pmid":"1394917","id":"PMC_1394917","title":"Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure.","date":"1992","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/1394917","citation_count":79,"is_preprint":false},{"pmid":"2529858","id":"PMC_2529858","title":"UK-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic.","date":"1989","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/2529858","citation_count":78,"is_preprint":false},{"pmid":"4038600","id":"PMC_4038600","title":"Structure-activity relationships of atrial natriuretic factor (ANF). II. Effect of chain-length modifications on vascular reactivity.","date":"1985","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/4038600","citation_count":78,"is_preprint":false},{"pmid":"17360769","id":"PMC_17360769","title":"Lack of the murine homeobox gene Hesx1 leads to a posterior transformation of the anterior forebrain.","date":"2007","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17360769","citation_count":68,"is_preprint":false},{"pmid":"7805853","id":"PMC_7805853","title":"Classical, novel and atypical isoforms of PKC stimulate ANF- and TRE/AP-1-regulated-promoter activity in ventricular cardiomyocytes.","date":"1994","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/7805853","citation_count":68,"is_preprint":false},{"pmid":"1826288","id":"PMC_1826288","title":"Anantin--a peptide antagonist of the atrial natriuretic factor (ANF). II. Determination of the primary sequence by NMR on the basis of proton assignments.","date":"1991","source":"The Journal of antibiotics","url":"https://pubmed.ncbi.nlm.nih.gov/1826288","citation_count":67,"is_preprint":false},{"pmid":"15670191","id":"PMC_15670191","title":"Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia.","date":"2005","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15670191","citation_count":63,"is_preprint":false},{"pmid":"1825155","id":"PMC_1825155","title":"Kidney function in ANF-transgenic mice: effect of blood volume expansion.","date":"1991","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/1825155","citation_count":62,"is_preprint":false},{"pmid":"14557462","id":"PMC_14557462","title":"Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia.","date":"2003","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/14557462","citation_count":61,"is_preprint":false},{"pmid":"2538834","id":"PMC_2538834","title":"Mammalian cAMP-responsive element can activate transcription in yeast and binds a yeast factor(s) that resembles the mammalian transcription factor ANF.","date":"1989","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2538834","citation_count":61,"is_preprint":false},{"pmid":"2827518","id":"PMC_2827518","title":"Glomerular ANF receptor regulation during changes in sodium and water metabolism.","date":"1988","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/2827518","citation_count":59,"is_preprint":false},{"pmid":"1652938","id":"PMC_1652938","title":"The presence of atrial-natriuretic-factor receptors of ANF-R2 subtype in rat platelets. Coupling to adenylate cyclase/cyclic AMP signal-transduction system.","date":"1991","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/1652938","citation_count":59,"is_preprint":false},{"pmid":"16940453","id":"PMC_16940453","title":"Novel HESX1 mutations associated with a life-threatening neonatal phenotype, pituitary aplasia, but normally located posterior pituitary and no optic nerve abnormalities.","date":"2006","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16940453","citation_count":58,"is_preprint":false},{"pmid":"2941632","id":"PMC_2941632","title":"Dopaminergic mediation of the diuretic and natriuretic effects of ANF in the rat.","date":"1986","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/2941632","citation_count":58,"is_preprint":false},{"pmid":"18775421","id":"PMC_18775421","title":"Genetic interaction between the homeobox transcription factors HESX1 and SIX3 is required for normal pituitary development.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18775421","citation_count":51,"is_preprint":false},{"pmid":"11558676","id":"PMC_11558676","title":"Regulation of the ANF and BNP promoters by GATA factors: lessons learned for cardiac transcription.","date":"2001","source":"Canadian journal of physiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11558676","citation_count":51,"is_preprint":false},{"pmid":"2173807","id":"PMC_2173807","title":"Degradation and clearance of atrial natriuretic factors (ANF).","date":"1990","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/2173807","citation_count":50,"is_preprint":false},{"pmid":"2570574","id":"PMC_2570574","title":"Urodilatin and beta-ANF: binding properties and activation of particulate guanylate cyclase.","date":"1989","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/2570574","citation_count":50,"is_preprint":false},{"pmid":"10843871","id":"PMC_10843871","title":"The Rho effector, PKN, regulates ANF gene transcription in cardiomyocytes through a serum response element.","date":"2000","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10843871","citation_count":49,"is_preprint":false},{"pmid":"772415","id":"PMC_772415","title":"Cooperative control of translational fidelity by ribosomal proteins in Escherichia coli. III. A ram mutation in the structural gene for protein S5 (rpx E).","date":"1976","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/772415","citation_count":48,"is_preprint":false},{"pmid":"8332060","id":"PMC_8332060","title":"Characterization of anf genes specific for the alternative nitrogenase and identification of nif genes required for both nitrogenases in Rhodobacter capsulatus.","date":"1993","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/8332060","citation_count":47,"is_preprint":false},{"pmid":"2945164","id":"PMC_2945164","title":"Localization and characterization of atrial natriuretic factor (ANF)-like peptide in the frog atrium.","date":"1986","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/2945164","citation_count":46,"is_preprint":false},{"pmid":"2998358","id":"PMC_2998358","title":"Structure-activity relationships of atrial natriuretic factor (ANF). III. Correlation of receptor affinity with relative potency on aldosterone production in zona glomerulosa cells.","date":"1985","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/2998358","citation_count":45,"is_preprint":false},{"pmid":"1721496","id":"PMC_1721496","title":"RT-PCR microlocalization of mRNA for guanylyl cyclase-coupled ANF receptor in rat kidney.","date":"1991","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/1721496","citation_count":43,"is_preprint":false},{"pmid":"15110720","id":"PMC_15110720","title":"Involvement of Pax6 and Otx2 in the forebrain-specific regulation of the vertebrate homeobox gene ANF/Hesx1.","date":"2004","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15110720","citation_count":42,"is_preprint":false},{"pmid":"7678266","id":"PMC_7678266","title":"Differential antimitogenic effectiveness of atrial natriuretic peptides in primary versus subcultured rat aortic smooth muscle cells: relationship to expression of ANF-C receptors.","date":"1993","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/7678266","citation_count":40,"is_preprint":false},{"pmid":"2845313","id":"PMC_2845313","title":"ANF receptors: distribution and regulation in central and peripheral tissues.","date":"1988","source":"Neuroscience and biobehavioral reviews","url":"https://pubmed.ncbi.nlm.nih.gov/2845313","citation_count":39,"is_preprint":false},{"pmid":"7594419","id":"PMC_7594419","title":"Atrial natriuretic factor modulates nitric oxide production: an ANF-C receptor-mediated effect.","date":"1995","source":"Journal of hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/7594419","citation_count":39,"is_preprint":false},{"pmid":"1313653","id":"PMC_1313653","title":"Captopril enhances renal responsiveness to ANF in dogs with compensated high-output heart failure.","date":"1992","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/1313653","citation_count":39,"is_preprint":false},{"pmid":"7547292","id":"PMC_7547292","title":"Heterogeneity within human-derived centers for disease control and prevention (CDC) coryneform group ANF-1-like bacteria and description of Corynebacterium auris sp. nov.","date":"1995","source":"International journal of systematic bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/7547292","citation_count":37,"is_preprint":false},{"pmid":"19093031","id":"PMC_19093031","title":"Analysis of mouse models carrying the I26T and R160C substitutions in the transcriptional repressor HESX1 as models for septo-optic dysplasia and hypopituitarism.","date":"2008","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/19093031","citation_count":35,"is_preprint":false},{"pmid":"17201807","id":"PMC_17201807","title":"Hormonal, pituitary magnetic resonance, LHX4 and HESX1 evaluation in patients with hypopituitarism and ectopic posterior pituitary lobe.","date":"2007","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17201807","citation_count":34,"is_preprint":false},{"pmid":"14646405","id":"PMC_14646405","title":"Clinical characteristics and molecular analysis of PIT1, PROP1,LHX3, and HESX1 in combined pituitary hormone deficiency patients with abnormal pituitary MR imaging.","date":"2003","source":"Hormone research","url":"https://pubmed.ncbi.nlm.nih.gov/14646405","citation_count":34,"is_preprint":false},{"pmid":"8494739","id":"PMC_8494739","title":"Taxonomic study of Corynebacterium Group ANF-1 strains: Proposal of Corynebacterium afermentans sp. nov. containing the subspecies C. afermentans subsp. afermentans subsp. nov. and C. afermentans subsp. lipophilum subsp. nov.","date":"1993","source":"International journal of systematic bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/8494739","citation_count":34,"is_preprint":false},{"pmid":"10673767","id":"PMC_10673767","title":"Dopamine induces a biphasic modulation of hypothalamic ANF neurons: a ligand concentration-dependent effect involving D5 and D2 receptor interaction.","date":"2000","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/10673767","citation_count":33,"is_preprint":false},{"pmid":"8468402","id":"PMC_8468402","title":"Immunocytochemical localization of atrial natriuretic factor (ANF)-like peptides in the brain and heart of the treefrog Hyla japonica: effect of weightlessness on the distribution of immunoreactive neurons and cardiocytes.","date":"1993","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/8468402","citation_count":33,"is_preprint":false},{"pmid":"8301562","id":"PMC_8301562","title":"Losartan improves the natriuretic response to ANF in rats with high-output heart failure.","date":"1994","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/8301562","citation_count":33,"is_preprint":false},{"pmid":"1838021","id":"PMC_1838021","title":"Cellular signals regulating the release of ANF.","date":"1991","source":"Canadian journal of physiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1838021","citation_count":32,"is_preprint":false},{"pmid":"18157385","id":"PMC_18157385","title":"Molecular analysis of PROP1, PIT1, HESX1, LHX3, and LHX4 shows high frequency of PROP1 mutations in patients with familial forms of combined pituitary hormone deficiency.","date":"2007","source":"Arquivos brasileiros de endocrinologia e metabologia","url":"https://pubmed.ncbi.nlm.nih.gov/18157385","citation_count":32,"is_preprint":false},{"pmid":"1473042","id":"PMC_1473042","title":"Role of spleen in ANF-induced reduction in plasma volume.","date":"1992","source":"Canadian journal of physiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1473042","citation_count":32,"is_preprint":false},{"pmid":"20389107","id":"PMC_20389107","title":"PROP1, HESX1, POU1F1, LHX3 and LHX4 mutation and deletion screening and GH1 P89L and IVS3+1/+2 mutation screening in a Dutch nationwide cohort of patients with combined pituitary hormone deficiency.","date":"2010","source":"Hormone research in paediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/20389107","citation_count":32,"is_preprint":false},{"pmid":"2839333","id":"PMC_2839333","title":"Involvement of Ni protein in the functional coupling of the atrial natriuretic factor (ANF) receptor to adenylate cyclase in rat lung plasma membranes.","date":"1988","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2839333","citation_count":31,"is_preprint":false},{"pmid":"7631892","id":"PMC_7631892","title":"Blood pressure and fluid-electrolyte balance in ANF-transgenic mice on high- and low-salt diets.","date":"1995","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/7631892","citation_count":30,"is_preprint":false},{"pmid":"19799869","id":"PMC_19799869","title":"beta-Catenin/TCF/LEF1 can directly regulate phenylephrine-induced cell hypertrophy and Anf transcription in cardiomyocytes.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19799869","citation_count":30,"is_preprint":false},{"pmid":"20874724","id":"PMC_20874724","title":"GATA4 regulates ANF expression synergistically with Sp1 in a cardiac hypertrophy model.","date":"2011","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20874724","citation_count":29,"is_preprint":false},{"pmid":"1443119","id":"PMC_1443119","title":"Pharmacokinetics of ANF and urodilatin during cANF receptor blockade and neutral endopeptidase inhibition.","date":"1992","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/1443119","citation_count":27,"is_preprint":false},{"pmid":"15465036","id":"PMC_15465036","title":"Transforming growth factor-beta induces the expression of ANF and hypertrophic growth in cultured cardiomyoblast cells through ZAK.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15465036","citation_count":26,"is_preprint":false},{"pmid":"18297730","id":"PMC_18297730","title":"The LIM-domain protein Zyxin binds the homeodomain factor Xanf1/Hesx1 and modulates its activity in the anterior neural plate of Xenopus laevis embryo.","date":"2008","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/18297730","citation_count":26,"is_preprint":false},{"pmid":"7649305","id":"PMC_7649305","title":"C-type natriuretic peptide and brain natriuretic peptide inhibit adenylyl cyclase activity: interaction with ANF-R2/ANP-C receptors.","date":"1995","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/7649305","citation_count":26,"is_preprint":false},{"pmid":"20181723","id":"PMC_20181723","title":"Corepressors TLE1 and TLE3 interact with HESX1 and PROP1.","date":"2010","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/20181723","citation_count":25,"is_preprint":false},{"pmid":"2522951","id":"PMC_2522951","title":"Localization of atrial natriuretic factor (ANF) binding sites in the central nervous system of the frog.","date":"1989","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/2522951","citation_count":25,"is_preprint":false},{"pmid":"11151301","id":"PMC_11151301","title":"Expression of atrial natriuretic factor (ANF) during Xenopus cardiac development.","date":"2000","source":"Development genes and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/11151301","citation_count":25,"is_preprint":false},{"pmid":"15895405","id":"PMC_15895405","title":"Comparative analysis of the natriuretic peptide precursor gene cluster in vertebrates reveals loss of ANF and retention of CNP-3 in chicken.","date":"2005","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15895405","citation_count":24,"is_preprint":false},{"pmid":"2972215","id":"PMC_2972215","title":"ANF inhibits vasopressin-induced Ca2+ mobilization and contraction in glomerular mesangial cells.","date":"1988","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/2972215","citation_count":24,"is_preprint":false},{"pmid":"7643524","id":"PMC_7643524","title":"Effects of urodilatin in the rat kidney: comparison with ANF and interaction with vasoactive substances.","date":"1995","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/7643524","citation_count":24,"is_preprint":false},{"pmid":"22296859","id":"PMC_22296859","title":"Characterization of a long-acting recombinant human serum albumin-atrial natriuretic factor (ANF) expressed in Pichia pastoris.","date":"2012","source":"Regulatory peptides","url":"https://pubmed.ncbi.nlm.nih.gov/22296859","citation_count":23,"is_preprint":false},{"pmid":"18853282","id":"PMC_18853282","title":"A novel SNP of the Hesx1 gene in bovine and its associations with average daily gain.","date":"2008","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/18853282","citation_count":22,"is_preprint":false},{"pmid":"7840642","id":"PMC_7840642","title":"Catalytic activation of guanylate cyclase/atrial natriuretic factor receptor by combined effects of ANF and GTP gamma S in plasma membranes of Leydig tumor cells: involvement of G-proteins.","date":"1995","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/7840642","citation_count":22,"is_preprint":false},{"pmid":"25500790","id":"PMC_25500790","title":"Molecular analysis of PROP1, POU1F1, LHX3, and HESX1 in Turkish patients with combined pituitary hormone deficiency: a multicenter study.","date":"2014","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/25500790","citation_count":22,"is_preprint":false},{"pmid":"15962313","id":"PMC_15962313","title":"Osteoblast calcium-sensing receptor has characteristics of ANF/7TM receptors.","date":"2005","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15962313","citation_count":22,"is_preprint":false},{"pmid":"2158751","id":"PMC_2158751","title":"Dehydration increases the density of C receptors for ANF on rat glomerular membranes.","date":"1990","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/2158751","citation_count":22,"is_preprint":false},{"pmid":"2847533","id":"PMC_2847533","title":"Blunted cGMP response to ANF in vascular smooth muscle cells of SHR.","date":"1988","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/2847533","citation_count":22,"is_preprint":false},{"pmid":"10626545","id":"PMC_10626545","title":"HESX1: a novel gene implicated in a familial form of septo-optic dysplasia.","date":"1999","source":"Acta paediatrica (Oslo, Norway : 1992). Supplement","url":"https://pubmed.ncbi.nlm.nih.gov/10626545","citation_count":21,"is_preprint":false},{"pmid":"16527264","id":"PMC_16527264","title":"Conserved regulatory elements establish the dynamic expression of Rpx/HesxI in early vertebrate development.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16527264","citation_count":21,"is_preprint":false},{"pmid":"1838022","id":"PMC_1838022","title":"Studies of ANF processing and secretion using a primary cardiocyte culture model.","date":"1991","source":"Canadian journal of physiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1838022","citation_count":21,"is_preprint":false},{"pmid":"21635224","id":"PMC_21635224","title":"Ca2+-induced PARP-1 activation and ANF expression are coupled events in cardiomyocytes.","date":"2011","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/21635224","citation_count":21,"is_preprint":false},{"pmid":"23465708","id":"PMC_23465708","title":"Identification of HESX1 mutations in Kallmann syndrome.","date":"2013","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/23465708","citation_count":21,"is_preprint":false},{"pmid":"2949627","id":"PMC_2949627","title":"A serum protease cleaves proANF into a 14-kilodalton peptide and ANF.","date":"1987","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/2949627","citation_count":21,"is_preprint":false},{"pmid":"17931718","id":"PMC_17931718","title":"DNMT1 interacts with the developmental transcriptional repressor HESX1.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17931718","citation_count":20,"is_preprint":false},{"pmid":"1322053","id":"PMC_1322053","title":"ANF and bradykinin synergistically inhibit transport in M-1 cortical collecting duct cell line.","date":"1992","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/1322053","citation_count":20,"is_preprint":false},{"pmid":"8386616","id":"PMC_8386616","title":"Ascorbic acid enhances forskolin-induced cyclic AMP production and pro-ANF mRNA expression of hypothalamic neurons in culture.","date":"1993","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8386616","citation_count":20,"is_preprint":false},{"pmid":"2953924","id":"PMC_2953924","title":"Comparative effect of ANF and various diuretics on isolated nephron segments.","date":"1987","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/2953924","citation_count":20,"is_preprint":false},{"pmid":"10843902","id":"PMC_10843902","title":"Sulfonylurea receptor ligands modulate stretch-induced ANF secretion in rat atrial myocyte culture.","date":"2000","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10843902","citation_count":20,"is_preprint":false},{"pmid":"1852117","id":"PMC_1852117","title":"CGRP and ANF cause relaxation of opossum internal anal sphincter via different mechanisms.","date":"1991","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/1852117","citation_count":19,"is_preprint":false},{"pmid":"1660404","id":"PMC_1660404","title":"Experimental glaucoma significantly decreases atrial natriuretic factor (ANF) receptors in the ciliary processes of the rabbit eye.","date":"1991","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/1660404","citation_count":19,"is_preprint":false},{"pmid":"2159278","id":"PMC_2159278","title":"Photoaffinity labelling of atrial natriuretic factor (ANF)-R1 receptor by underivatized 125I-ANF. Involvement of lipid peroxidation.","date":"1990","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/2159278","citation_count":18,"is_preprint":false},{"pmid":"20949537","id":"PMC_20949537","title":"Candidate gene sequencing of LHX2, HESX1, and SOX2 in a large schizencephaly cohort.","date":"2010","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/20949537","citation_count":17,"is_preprint":false},{"pmid":"1838026","id":"PMC_1838026","title":"Developing essential hypertension: a syndrome involving ANF deficiency?","date":"1991","source":"Canadian journal of physiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1838026","citation_count":16,"is_preprint":false},{"pmid":"1417928","id":"PMC_1417928","title":"The pharmacokinetics of 125I-atrial natriuretic factor in anaesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade.","date":"1992","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1417928","citation_count":16,"is_preprint":false},{"pmid":"1838029","id":"PMC_1838029","title":"Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action.","date":"1991","source":"Canadian journal of physiology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1838029","citation_count":16,"is_preprint":false},{"pmid":"1838723","id":"PMC_1838723","title":"Proteinase activities in bovine atrium and the possible role of mast cell tryptase in the processing of atrial natriuretic factor (ANF).","date":"1991","source":"Comparative biochemistry and physiology. B, Comparative biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1838723","citation_count":16,"is_preprint":false},{"pmid":"7918434","id":"PMC_7918434","title":"Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA.","date":"1994","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7918434","citation_count":16,"is_preprint":false},{"pmid":"8745272","id":"PMC_8745272","title":"Localization of mRNA coding for the three subtypes of atrial natriuretic factor (ANF) receptors in rat anterior pituitary gland cells.","date":"1995","source":"Journal of neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8745272","citation_count":16,"is_preprint":false},{"pmid":"12885556","id":"PMC_12885556","title":"A novel inducible element, activated by contact with Rathke's pouch, is present in the regulatory region of the Rpx/Hesx1 homeobox gene.","date":"2003","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12885556","citation_count":15,"is_preprint":false},{"pmid":"2962866","id":"PMC_2962866","title":"Chemical synthesis and structure-activity relations for ANF analogues.","date":"1987","source":"Endocrinology and metabolism clinics of North America","url":"https://pubmed.ncbi.nlm.nih.gov/2962866","citation_count":15,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49391,"output_tokens":4213,"usd":0.105684},"stage2":{"model":"claude-opus-4-6","input_tokens":7658,"output_tokens":3211,"usd":0.177847},"total_usd":0.283531,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"HESX1 encodes a homeodomain transcription factor required for forebrain, midline, and pituitary development; the Arg53Cys missense mutation within the homeodomain destroys its ability to bind target DNA in vitro.\",\n      \"method\": \"Homozygous knock-out mouse, human mutation screening, in vitro DNA binding assay (gel shift)\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — loss-of-function mouse model with defined phenotype plus in vitro DNA-binding assay; foundational paper with 511 citations\",\n      \"pmids\": [\"9620767\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Hesx1 (Rpx) is expressed as two transcripts encoding an identical 185-amino-acid homeodomain protein; its homeodomain shares 80% identity with Xenopus XANF-1, defining a new homeodomain class; expression is restricted to early embryonic tissues and is absent in adult mice.\",\n      \"method\": \"Molecular cloning, Northern blot, sequence analysis of transcripts from embryonic stem cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — primary molecular characterization with sequence, transcript analysis, and expression profiling; foundational paper\",\n      \"pmids\": [\"7876132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"HESX1 is a promoter-specific transcriptional repressor with a minimal 36-amino-acid repression domain that suppresses homeodomain-containing activator proteins; disease-associated mutations (R160C, S170L) reduce DNA-binding affinity (wild-type Kd 31 nM; S170L Kd 150 nM; R160C no binding), and R160C acts as a dominant negative by inhibiting wild-type HESX1 DNA binding both in vitro and in cell culture via the repression domain.\",\n      \"method\": \"Promoter-specific reporter assays, EMSA/gel shift with quantitative Kd measurement, dominant-negative cell culture transfection, deletion mutagenesis of repression domain\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal in vitro and cell-based assays with mutagenesis in a single rigorous study\",\n      \"pmids\": [\"11748154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Heterozygous HESX1 missense mutation S170L significantly reduces relative DNA-binding activity compared with wild-type HESX1, as demonstrated by gel shift analysis.\",\n      \"method\": \"Gel shift (EMSA) assay of mutant HESX1-S170L protein\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — single direct biochemical assay, single lab, consistent with findings in PMID 11748154\",\n      \"pmids\": [\"11136712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A homozygous I26T mutation in the Engrailed homology 1 (eh1) repressor domain of HESX1 does not affect DNA binding but impairs recruitment of the Groucho/TLE1 corepressor, leading to partial loss of transcriptional repression; this establishes the eh1 domain as the interface for TLE corepressor interaction.\",\n      \"method\": \"In vitro DNA binding assay, corepressor recruitment assay, reporter gene repression assay in cell culture, patient mutation analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal assays (DNA binding, corepressor interaction, transcriptional repression) in a single well-controlled study\",\n      \"pmids\": [\"14561704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A frameshift deletion mutation (g.1684delG) in HESX1 produces a mutant protein with increased DNA binding, causing enhanced repression of PROP1-dependent gene activity, revealing that gain-of-repressor-function is a novel disease mechanism.\",\n      \"method\": \"Reporter gene assay measuring PROP1-mediated transcriptional activation in the presence of mutant HESX1\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-based functional assay with clear mechanistic outcome, single lab\",\n      \"pmids\": [\"14557462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"HESX1 interacts with both TLE1 and TLE3 corepressors through its engrailed homology domain to repress PROP1-mediated transcription; TLE1 and TLE3 can also repress PROP1 independently of HESX1 via protein-protein interaction, and ectopic HESX1 expression in transgenic mouse pituitary suppresses terminal differentiation of thyrotrophs and gonadotrophs.\",\n      \"method\": \"Cell-based reporter assay, co-immunoprecipitation, transgenic mouse overexpression with cell-type differentiation phenotyping\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reciprocal Co-IP, functional reporter assay, and in vivo transgenic validation with multiple orthogonal methods\",\n      \"pmids\": [\"20181723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"DNMT1 (DNA methyltransferase 1) is a HESX1-binding protein identified by yeast two-hybrid screen; interaction requires the entire HESX1 protein and a portion of the DNMT1 N-terminus plus its C-terminal catalytic domain; HESX1-DNMT1 complexes co-immunoprecipitate from cells and co-localise in the nucleus, suggesting DNMT1 recruitment as a mechanism for HESX1-mediated transcriptional repression.\",\n      \"method\": \"Yeast two-hybrid screen, deletion mapping, co-immunoprecipitation, co-localisation by immunofluorescence\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — yeast two-hybrid plus Co-IP plus co-localisation; functional consequence inferred but not directly tested, single lab\",\n      \"pmids\": [\"17931718\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Absence of Hesx1 leads to ectopic activation of Wnt/β-catenin signalling within the anterior forebrain expression domain of Hesx1, causing posterior transformation of the anterior forebrain; conditional re-expression of Hesx1 within the anterior forebrain rescues the forebrain defect, establishing that Hesx1 represses Wnt/β-catenin signalling cell-autonomously in the anterior neural plate.\",\n      \"method\": \"Genetic cell labelling, marker analysis, epistasis via conditional transgenic rescue, in situ hybridisation for Wnt target genes in Hesx1-/- mice\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis/conditional rescue with genetic cell labelling and molecular markers, strong mechanistic placement within Wnt pathway\",\n      \"pmids\": [\"17360769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Hesx1 is required cell-autonomously in the anterior neural ectoderm (ANE) for normal forebrain formation; chimera analysis shows that Hesx1-/- visceral endoderm does not cause forebrain defects, but Hesx1-/- cells in the ANE do; absence of Hesx1 in ANE leads to downregulation of Six3 and Rax/Rx by the early somite stage.\",\n      \"method\": \"Chimeric embryo analysis (ES cell injection into blastocysts), RNA in situ hybridisation for forebrain markers\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — chimeric analysis provides cell-autonomous placement with molecular marker validation\",\n      \"pmids\": [\"10882526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Hesx1 and Six3 interact genetically in pituitary development: compound heterozygous Six3+/-;Hesx1Cre/+ mice display severe dwarfism and pituitary hypoplasia with expanded and bifurcated Rathke's pouch, phenocopying Hesx1-null defects, revealing a cooperative epistatic relationship between these two homeobox genes in anterior pituitary organogenesis.\",\n      \"method\": \"Double-heterozygous compound mutant mouse analysis, histology, cell proliferation assays, endocrine phenotyping\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis via compound mutant with defined cellular and endocrine phenotype\",\n      \"pmids\": [\"18775421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The Xanf1/Hesx1 homeodomain repressor binds the LIM-domain protein Zyxin; the eh1 (Engrailed-type) repressor domain of Xanf1 and LIM2-domain of Zyxin are primarily responsible for the interaction; Zyxin overexpression phenocopies Xanf1 loss-of-function, while repressor-fused Zyxin mimics Xanf1 overexpression, indicating Zyxin acts as a negative modulator of Xanf1 transcriptional repressing activity in the anterior neural plate.\",\n      \"method\": \"Co-immunoprecipitation, deletion mutant mapping, Xenopus overexpression/loss-of-function embryo assay\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP with domain mapping plus in vivo Xenopus functional assay, ortholog context consistent with mammalian HESX1\",\n      \"pmids\": [\"18297730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The transcription factor Otx2 binds conserved sites in the ANF/Hesx1 promoter and is required for its activation in the anterior embryonic region; Pax6 binds a site near the transcriptional start site and inhibits Hesx1 expression (Pax6-/- mice show expanded Hesx1 domain); these factors are key regulators of forebrain-specific Hesx1 gene expression.\",\n      \"method\": \"Transgenic reporter analysis, in vivo electroporation in chick, Pax6 knockout mouse in situ hybridisation, gel shift/in vivo ChIP-like binding assays\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo promoter analysis with multiple species, loss-of-function genetics, and binding site characterisation; single lab\",\n      \"pmids\": [\"15110720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Regulatory sequences in the 5' upstream region of Rpx/Hesx1 control early expression in anterior endoderm/neural plate, while 3' regulatory elements are required for late expression in Rathke's pouch; the LIM homeodomain proteins Lim1/Lhx1 and Lhx3 directly bind two LIM protein-binding sites in the 5' upstream region, which are required for Rpx promoter activity in both mice and Xenopus.\",\n      \"method\": \"Transgenic mouse reporter assay with deletion analysis, EMSA for LIM protein binding to promoter sites, cross-species conservation analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — transgenic deletion analysis plus direct binding assay with two species validation\",\n      \"pmids\": [\"16527264\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Knock-in of the I26T mutation (in the eh1 repressor domain) produces a hypomorphic allele with pituitary defects comparable to Hesx1-null but normal telencephalon, while knock-in of R160C (homeodomain) produces a null allele with forebrain and pituitary defects identical to Hesx1-null mice, demonstrating that eh1 and homeodomain mutations have distinct phenotypic consequences consistent with their distinct molecular defects (corepressor recruitment vs. DNA binding).\",\n      \"method\": \"Knock-in mouse models, histological and developmental phenotyping, comparison with null allele\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two independent knock-in alleles with defined molecular defects correlated to in vivo phenotypic outcome\",\n      \"pmids\": [\"19093031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"In Ames dwarf (df) mutant mice, Rpx (Hesx1) expression is not extinguished in the pituitary on embryonic day 13.5, while in Snell dwarf (Pit1dw) mutants Rpx is appropriately downregulated; double-mutant epistasis shows df acts upstream of Pit1 in the pituitary differentiation cascade, placing Hesx1 downregulation as a prerequisite for lineage-specific cell proliferation.\",\n      \"method\": \"Genetic epistasis with double-mutant analysis, in situ hybridisation for Rpx expression, cell proliferation assays\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with double-homozygous and double-heterozygous analysis plus molecular marker expression\",\n      \"pmids\": [\"8961267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Two novel homozygous HESX1 mutations (frameshift c.449_450delAC and splice defect c.357+2T>C) produce truncated proteins lacking most or all of the homeodomain that are unable to repress PROP1 activity in a transcriptional reporter assay, confirming that HESX1 repressor function requires an intact homeodomain.\",\n      \"method\": \"Patient mutation sequencing, transcript analysis, transcriptional repression reporter assay\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional assay of mutant proteins, mechanistically informative, single lab\",\n      \"pmids\": [\"16940453\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HESX1 is a paired-like homeodomain transcriptional repressor that acts in the anterior neural ectoderm during early embryogenesis: it binds target DNA via its homeodomain (disrupted by R160C), recruits Groucho/TLE1/TLE3 corepressors via its N-terminal eh1 domain (disrupted by I26T), and DNMT1 via a broader interaction, to suppress homeodomain activators such as PROP1 and repress Wnt/β-catenin signalling in the anterior forebrain; its expression is controlled by Lhx1/Lhx3 (early), Otx2 (activation), and Pax6 (repression), and it interacts genetically with Six3 during pituitary organogenesis, with loss-of-function causing septo-optic dysplasia and hypopituitarism while gain-of-repressor-function mutations also cause congenital pituitary disease.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HESX1 is a paired-like homeodomain transcriptional repressor essential for anterior forebrain, midline, and pituitary development during early embryogenesis. It acts cell-autonomously in the anterior neural ectoderm, where it suppresses Wnt/β-catenin signalling and represses homeodomain activators such as PROP1 by recruiting TLE1/TLE3 (Groucho family) corepressors through its N-terminal engrailed homology 1 (eh1) domain and binding target DNA via its homeodomain (Kd ~31 nM), with DNMT1 also recruited as an additional corepressor partner [PMID:11748154, PMID:14561704, PMID:20181723, PMID:17931718, PMID:17360769]. Knock-in studies show that disruption of DNA binding (R160C) phenocopies the null, whereas disruption of TLE recruitment alone (I26T) produces a hypomorphic phenotype with pituitary defects but a normal telencephalon, demonstrating separable domain contributions to forebrain versus pituitary specification [PMID:19093031]. Loss-of-function mutations cause septo-optic dysplasia and combined pituitary hormone deficiency, while a gain-of-repressor-function frameshift mutation reveals that excessive HESX1-mediated repression of PROP1 is also pathogenic [PMID:9620767, PMID:14557462].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing that Hesx1 (Rpx) encodes a novel 185-amino-acid homeodomain protein expressed exclusively in early embryonic tissues defined the gene as a developmental transcription factor.\",\n      \"evidence\": \"Molecular cloning, Northern blot, and sequence analysis from embryonic stem cells\",\n      \"pmids\": [\"7876132\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional assay performed\", \"Target genes and binding sites unknown\", \"Protein-protein interactions uncharacterized\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Epistasis analysis placed Hesx1 downstream of the Ames dwarf (Prop1) locus and showed that persistent Hesx1 expression blocks pituitary lineage-specific proliferation, establishing Hesx1 downregulation as a prerequisite for pituitary differentiation.\",\n      \"evidence\": \"Double-mutant epistasis in df and Pit1dw mice with in situ hybridisation and cell proliferation assays\",\n      \"pmids\": [\"8961267\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional relationship between PROP1 and HESX1 not tested\", \"Mechanism of Hesx1 downregulation unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrating that Hesx1-null mice have forebrain, midline, and pituitary defects and that a patient R53C homeodomain mutation abolishes DNA binding established HESX1 as a disease gene for septo-optic dysplasia and linked its function to homeodomain-mediated DNA binding.\",\n      \"evidence\": \"Knockout mouse phenotyping, human mutation screening, gel-shift DNA binding assay\",\n      \"pmids\": [\"9620767\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional targets not identified\", \"Repression mechanism unknown\", \"Heterozygous vs homozygous genotype-phenotype correlation incomplete\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Chimera analysis resolved the tissue requirement, showing Hesx1 is needed cell-autonomously in the anterior neural ectoderm (not visceral endoderm) and its absence leads to loss of Six3 and Rax expression, placing it upstream of these forebrain determinants.\",\n      \"evidence\": \"ES-cell chimeric embryo analysis with RNA in situ hybridisation\",\n      \"pmids\": [\"10882526\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Hesx1 directly regulates Six3/Rax transcription or acts indirectly not determined\", \"Downstream signalling pathways not identified\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Quantitative biochemistry and reporter assays showed HESX1 is a promoter-specific transcriptional repressor that opposes homeodomain activators, with a minimal 36-amino-acid repression domain, and revealed that R160C acts as a dominant negative by sequestering wild-type protein through this domain.\",\n      \"evidence\": \"EMSA with Kd measurements, deletion mutagenesis, cell-based reporter assays, dominant-negative transfection experiments\",\n      \"pmids\": [\"11748154\", \"11136712\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the endogenous corepressor recruited by the repression domain not yet known\", \"Direct genomic targets not identified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification that the I26T eh1-domain mutation disrupts TLE1 corepressor recruitment without affecting DNA binding, while a gain-of-function frameshift increases DNA binding and repression, established two distinct disease mechanisms — loss of corepressor recruitment and gain of repressor function.\",\n      \"evidence\": \"Corepressor recruitment assays, DNA binding assays, PROP1-dependent reporter assays, patient mutation analysis\",\n      \"pmids\": [\"14561704\", \"14557462\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TLE1 is the sole corepressor mediating HESX1 repression in vivo unknown\", \"Structural basis of eh1-TLE interaction not resolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Upstream regulation was defined: Otx2 directly activates Hesx1 through conserved promoter sites, while Pax6 represses it, explaining how Hesx1 expression is restricted to the anterior forebrain domain.\",\n      \"evidence\": \"Transgenic reporter analysis, in vivo electroporation in chick, Pax6 knockout mouse in situ hybridisation, binding assays\",\n      \"pmids\": [\"15110720\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Otx2 and Pax6 are sufficient to account for all spatial regulation not tested\", \"Chromatin context of regulation not examined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identification of Lhx1/Lhx3 binding sites in the 5' upstream region and separate 3' elements for Rathke's pouch expression resolved the modular regulatory architecture of the Hesx1 locus across developmental stages.\",\n      \"evidence\": \"Transgenic mouse reporter deletion analysis and EMSA for LIM protein binding, cross-species validation\",\n      \"pmids\": [\"16527264\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo occupancy by Lhx1/Lhx3 not confirmed by ChIP\", \"How 3' regulatory elements integrate with 5' elements during the transition from neural plate to Rathke's pouch unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Discovery that HESX1 represses Wnt/β-catenin signalling cell-autonomously in the anterior forebrain, with conditional rescue reversing anterior-to-posterior transformation, placed HESX1 squarely within the Wnt antagonism pathway during forebrain patterning.\",\n      \"evidence\": \"Conditional transgenic rescue in Hesx1-null mice, genetic cell labelling, in situ hybridisation for Wnt targets\",\n      \"pmids\": [\"17360769\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct Wnt pathway target genes repressed by HESX1 not identified\", \"Whether HESX1 represses Wnt ligands, receptors, or intracellular components unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identification of DNMT1 as a HESX1-interacting protein suggested an epigenetic repression mechanism involving DNA methylation, adding a second corepressor axis beyond TLE.\",\n      \"evidence\": \"Yeast two-hybrid screen, deletion mapping, co-immunoprecipitation, immunofluorescence co-localisation\",\n      \"pmids\": [\"17931718\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of HESX1-DNMT1 interaction on target gene methylation not demonstrated\", \"Interaction not validated at endogenous expression levels\", \"Relevance in vivo not tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Knock-in of I26T (eh1) and R160C (homeodomain) mutations in mice dissected domain contributions in vivo: the homeodomain null phenocopies the full knockout (forebrain + pituitary defects), while the eh1 hypomorph selectively disrupts pituitary development, demonstrating that corepressor recruitment is specifically critical for pituitary but dispensable for telencephalon specification.\",\n      \"evidence\": \"Two independent knock-in mouse models with histological and developmental phenotyping compared to null allele\",\n      \"pmids\": [\"19093031\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why the eh1 domain is dispensable for forebrain function not mechanistically explained\", \"Alternative corepressor recruitment in the forebrain not investigated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Genetic interaction between Hesx1 and Six3 was demonstrated by compound heterozygotes exhibiting severe pituitary hypoplasia, establishing a cooperative epistatic network between these homeobox genes in anterior pituitary organogenesis.\",\n      \"evidence\": \"Compound heterozygous Six3+/-;Hesx1Cre/+ mice with histology, proliferation, and endocrine phenotyping\",\n      \"pmids\": [\"18775421\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HESX1 and Six3 regulate shared target genes or act in parallel unknown\", \"Biochemical interaction between HESX1 and SIX3 proteins not tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Expanded characterisation showed HESX1 represses PROP1-mediated transcription through both TLE1 and TLE3, and that persistent HESX1 expression in transgenic pituitary suppresses terminal differentiation of thyrotrophs and gonadotrophs, confirming the in vivo repressor role against PROP1-driven differentiation.\",\n      \"evidence\": \"Co-immunoprecipitation, cell-based reporter assay, transgenic mouse pituitary overexpression with cell-type differentiation phenotyping\",\n      \"pmids\": [\"20181723\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct genomic binding sites of the HESX1-TLE complex on PROP1 targets not mapped\", \"Whether TLE1 and TLE3 are redundant or have distinct roles in pituitary cell fate not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The direct genomic targets of HESX1 remain unidentified genome-wide; the structural basis for its interactions with TLE corepressors and DNMT1 is unresolved; and the mechanism by which it selectively antagonises Wnt/β-catenin signalling in the anterior forebrain has not been molecularly defined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No ChIP-seq or equivalent genome-wide binding data\", \"No structural model of HESX1 or its corepressor complexes\", \"Wnt target gene specificity of HESX1-mediated repression unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 2, 3, 14, 16]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 4, 5, 6, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0074160\", \"supporting_discovery_ids\": [2, 4, 5, 6, 16]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 8, 9, 10, 14, 15]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"TLE1\", \"TLE3\", \"DNMT1\", \"PROP1\", \"SIX3\", \"ZYX\"],\n    \"other_free_text\": []\n  }\n}\n```"}